|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Expression of urotensin-Ⅱ in human coronary atherosclerosis显示文摘 | Hassan GS Douglas SA Ohlstein EH | 2005 | Peptide2005，26，12： | 1 |
| 2 | Cortial bone blood flow in loose and tight fitting locking undreamed intramedullary nailing: a canie segmental tibia frature moder显示文摘 | Hupel TM Aksenow SA Schemitsch EH | 1998 | J Orthop Trauma1998，12，2： | 1 |
| 3 | Localization of urotensin-Ⅱ immunoreactivity in normal human kidneys and renal carcinoma显示文摘 | Shenouda A Douglas SA Ohlstein EH | 2002 | J Histochem Cytochem2002，50，7： | 1 |
| 4 | Localization of urotensin -Ⅱ immunoreactivity in normal human kidneys and renal carcinoma 显示文摘 | Shenouda A Douglas SA Ohlstein EH | 2002 | J Histochem Cytochem2002，50，7： | 1 |
| 5 | Human urotensin Ⅱ,the most potent mammalian vasoconstrictor identified to date,as a therapeutic target for the management of cardiovascular disease显示文摘 | Ohlstein EH | 2000 | Trends Cardiovasc Med2000，10，： | 1 |
| 6 | Muscle perfusion after intramedullary nailing of the canine tibia显示文摘 | Hupel TM Aksenov SA Schemitsch EH | 1998 | J Trauma1998，45，2： | 1 |
| 7 | Doose syndrome (myoclonic-astatic epilepsy) :40 years of progress 显示文摘 | Kelly SA Kossoff EH | 2010 | Dev Med Child Neurol2010，52，11： | 1 |
| 8 | Human urotensin II,the most potent mammalian vasoconstrictor identified to date,as a therapeutic target for the management of cardiovascular disease显示文摘 | Douglas SA Ohlstein EH | 2000 | Trends Cardiovasc Med2000，10，： | 1 |
| 9 | Viral causes of bovine abortion in Ohio显示文摘 | Sattar SA Bohl EH Senturk M | 1965 | Journal of American MedicalAssociation1965，147，： | 1 |
| 10 | ( 1998 ) Corticol bone blood flow in loose and tight fitting locked unreamed intramodullary nailing: canine segmen taltibia fracture mode 显示文摘 | Hupel TM Aksenov SA Schemitsch EH | 1998 | J orthop Trauma1998，12，2： | 1 |
| 11 | Vancemycin resistance plasmid in Enterococcus faecails that encodes sensitivity to a sex pheromone also produced by Staphylococcus aureus显示文摘 | Showsh SA DeBorvre EH Clewell DB | 2001 | Antimicrob Agents Chemother2001，45，7： | 1 |
| 12 | Human urotensin-II,the most potent mammalian vasoconstrictor identified to date,as a therapeutic target for the management of cardiovascular disease显示文摘 | Douglas SA Ohlstein EH | 2000 | Trends Cardiovasc Med2000，10，6： | 1 |
| 13 | Herbal medicine Gamgungtang down-regulates autoimmunity through induction of TH2 cytokine production by lymphocytes in experimental thyroiditis model显示文摘 | Sa EH Jin UH Kim DS | 2007 | Journal of Ethnopharmacology2007，109，： | 1 |
| 14 | Cephalometric analysis: comparisons between maximum intercuspation and centric relation显示文摘 | Williamson EH Caves SA Edenfield R J | 1978 | Am J Orthod1978，74，6： | 1 |
| 15 | Congestive heart failare and expresion of myocardial urotensin Ⅱ显示文摘 | Dou as SA Tayara L Ohlstein EH | 2002 | Lancet2002，359，： | 1 |
| 16 | Human Urotensin-Ⅱ,the most potent mammalian vasoconstrictor identified to date,as a therapeutic target for the manegement of cardiovascular disease显示文摘 | Douglas SA Ohlestein EH | 2000 | Trends Cardiovasc Med2000，10，6： | 1 |
| 17 | Mutation of the MENIN gene in sporadic pancreatic endocrine tumors显示文摘 | Wang EH Ebrahimi SA Wu AY | 1998 | Cancer Res1998，58，19： | 1 |
| 18 | Various oscillationpatterns of serum fibroblast growth factor 21 concentrationsin healthy volunteers显示文摘 | Lee SA Jeong E Kim EH | 2012 | Diabetes Metab J2012，36，1： | 1 |
| 19 | Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury显示文摘 | Ohlstein EH Douglas SA Sung CP | 1993 | Proc Natl Acad Sci USA1993，90，13： | 1 |
| 20 | Localizadon of urotcnsin Ⅱ immunoreactivity in normal human kidneys and renal carcinoma显示文摘 | Shenouda A Douglas SA Ohlstein EH | 2002 | J Histochem Cytochem2002，50，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员